Cochlear implant maker Med-El USA said yesterday it won FDA de novo clearance for its Bonebridge bone conducting hearing implant system, with plans to launch the device this year. The newly cleared system is indicated for individuals 12 years and older with conductive hearing loss, mixed hearing loss or single-sided deafness, the Durham, N.C.-based company said. The […]
Otolaryngology/Ear, Nose & Throat (ENT)
EndoGastric Solutions raises $25m
EndoGastric Solutions has raised $25.4 million in equity from 28 investors as part of a $35.5 million offering, according to a document filed with the SEC this week. The Washington-based company has not yet publicly stated what it plans to do with its newly-acquired funds. EndoGastric Solutions sells a device designed to reconstruct the gastroesophageal […]
Cochlear launches Nucleus app for Android devices
Cochlear Ltd. (ASX:COH) said today it launched a Google (NSDQ:GOOG) Android compatible version of its Nucleus smart application designed for use with its Nucleus 7 sound processor. With the update, users of the Nucleus 7 with Android devices can control their hearing through the linked application, and will gain access to a number of new features previously […]
Preceptis Medical closes Series B
Preceptis Medical said yesterday it closed a Series B round of financing to help support its Hummingbird tympanostomy tube system designed for pediatric ear tube placement procedures. The Plymouth, Minn.-based company’s Hummingbrid TTS tympanostomy tube system is designed to reduce pain for pediatric patients undergoing ear tube procedures, allowing moderate, conscious sedation with no need for […]
Neurent Medical sniffs out $11m for rhinitis device
Neurent Medical reportedly sniffed out a funding round of nearly $12 million for the minimally invasive rhinitis treatment it’s developing. The €9.3 million round for Oranmore, Ireland-based Neurent was led by Irish venture capital shop Fountain Healthcare Partners and included participation from Atlantic Bridge, Ireland’s Western Development Commission, Enterprise Ireland and a syndicate of U.S. and Irish medical […]
PavMed subsidiary Lucid Dx inks licensing deal with Case Western Univ.
Pavmed (NSDQ:PAVM) subsidiary Lucid Diagnostics said today it finalized a licensing agreement with Case Western Reserve University to commercialize its EsoCheck non-invasive cell sampling device and DNA biomarker test. The New York-based company said that the EsoCheck device has been shown to effectively and accurately detect Barrett’s Esophagus, which is a precursor to the most common […]
Med-El wins FDA nod for Rondo 2 cochlear implant audio processor
Cochlear implant maker Med-El USA said today it won FDA approval for its Rondo 2 cochlear implant audio processor with an expected launch of the device this fall. The Durham, N.C.-based ocmpany said the newly cleared Rondo 2 audio processor features wireless charging capabilities that allow the device to fully recharge in four hours after being […]
Sivantos, Widex merge to form 3rd largest hearing aid maker
Hearing aid maker Sivantos, formerly Siemens (NYSE:SI) audiology biz now owned by PE firm EQT, announced plans this week to merge with Danish hearing aid maker Widex in a deal that could make the merged group the third largest player in the hearing aid market, according to a Reuters report. The merged company is expected to have […]
Hoya gets in on $15m round for 3NT Medical
3NT Medical said today that it drummed up “a major portion” of its maiden $15 million funding round from Japan’s Hoya Corp. (TYO:7741) Rosh Ha’Ayin, Israel-based 3NT is developing the Sinusway drivable endoscope for ear, nose and throat procedures. Proceeds from the round are slated for commercializing Sinusway in the U.S. and Europe and the completion of […]
Pavmed registers for $20m rights offering
Pavmed (NSDQ:PAVM) said today that it filed a preliminary prospectus with the SEC for an offering of the rights to buy a new unit in exchange for each share of outstanding common stock. The medical device company plans to offer the rights to purchase up to 9 million units at $2.25 apiece on May 21, valuing […]
J&J’s Acclarent launches TruDi ENT nav system
Johnson & Johnson‘s (NYSE:JNJ) Acclarent said late last month it launched the TruDi real-time, three-dimensional navigation system designed for ENT procedures. Acclarent said that the first commercial procedures were performed with the device on April 16, after having previously won FDA 510(k) clearance. The TruDi system is an electromagnetic image-guided navigation system designed for endoscopic sinus […]